Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Eli Lillys famous weight loss drug will now be sold in India after the drug maker received approval from CDSCO. What are its ...

Mounjaro, Eli Lilly's diabetes and obesity drug, is now available in India at a fraction of its US price. It offers treatment for weight loss and diabetes control, but watch out for the side effects ...

The palace has still not disclosed the type of cancer Charles has, with a palace source revealing to The Times that this is a ...

In 1998, shortly after arriving for work, a Tennessee high-school teacher reported a "gasoline-like smell" and feeling dizzy.

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

What you need to know about opioid overdose reversal drug nalmefene’s risks, effectiveness and clinical concerns ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted the public on falsified Oxycontin 80mg ...

The primary value of placebo controls in clinical trials is the minimization of bias.